[go: up one dir, main page]

FI973164A7 - Antipsykotiska 4-(1H-indolyl-1-yl)-1-substituerade piperidinderivat - Google Patents

Antipsykotiska 4-(1H-indolyl-1-yl)-1-substituerade piperidinderivat Download PDF

Info

Publication number
FI973164A7
FI973164A7 FI973164A FI973164A FI973164A7 FI 973164 A7 FI973164 A7 FI 973164A7 FI 973164 A FI973164 A FI 973164A FI 973164 A FI973164 A FI 973164A FI 973164 A7 FI973164 A7 FI 973164A7
Authority
FI
Finland
Prior art keywords
antipsychotic
indolyl
substituted piperidine
piperidine derivatives
derivatives
Prior art date
Application number
FI973164A
Other languages
English (en)
Finnish (fi)
Other versions
FI973164A0 (sv
FI973164L (sv
Inventor
Josephus Carolus Mertens
Jan Vandenberk
Ludo Edmond Josephine Kennis
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of FI973164A0 publication Critical patent/FI973164A0/sv
Publication of FI973164A7 publication Critical patent/FI973164A7/sv
Publication of FI973164L publication Critical patent/FI973164L/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI973164A 1995-01-31 1996-01-23 Antipsykotiska 4-(1H-indolyl-1-yl)-1-substituerade piperidinderivat FI973164L (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP95200229 1995-01-31
PCT/EP1996/000363 WO1996023784A1 (en) 1995-01-31 1996-01-23 Antipsychotic 4-(1h-indolyl-1-yl)-1-substituted piperidine derivatives

Publications (3)

Publication Number Publication Date
FI973164A0 FI973164A0 (sv) 1997-07-30
FI973164A7 true FI973164A7 (sv) 1997-07-30
FI973164L FI973164L (sv) 1997-07-30

Family

ID=8219983

Family Applications (1)

Application Number Title Priority Date Filing Date
FI973164A FI973164L (sv) 1995-01-31 1996-01-23 Antipsykotiska 4-(1H-indolyl-1-yl)-1-substituerade piperidinderivat

Country Status (21)

Country Link
US (1) US5919788A (sv)
EP (1) EP0808313B1 (sv)
JP (1) JP3980054B2 (sv)
KR (1) KR100415391B1 (sv)
CN (1) CN1152874C (sv)
AR (1) AR002025A1 (sv)
AT (1) ATE247105T1 (sv)
AU (1) AU702931B2 (sv)
BR (1) BR9606815A (sv)
CA (1) CA2210913C (sv)
DE (1) DE69629454T2 (sv)
ES (1) ES2205015T3 (sv)
FI (1) FI973164L (sv)
IL (1) IL116930A (sv)
MY (1) MY130950A (sv)
NO (1) NO308537B1 (sv)
NZ (1) NZ301264A (sv)
PL (1) PL183291B1 (sv)
TW (1) TW421649B (sv)
WO (1) WO1996023784A1 (sv)
ZA (1) ZA96702B (sv)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI242011B (en) 1997-03-31 2005-10-21 Eisai Co Ltd 1,4-substituted cyclic amine derivatives
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
US6204274B1 (en) 1998-04-29 2001-03-20 American Home Products Corporation Indolyl derivatives as serotonergic agents
TW528754B (en) * 1998-04-29 2003-04-21 Wyeth Corp Indolyl derivatibes as serotonergic agents
GB9810886D0 (en) * 1998-05-13 1998-07-22 Lilly Industries Ltd Pharmaceutical compounds
CN101014601B (zh) * 2004-09-09 2011-09-14 詹森药业有限公司 制备9-羟基-3-(2-羟基乙基)-2-甲基-4H-吡啶并[1,2-a]嘧啶-4-酮及其晶体
US7820816B2 (en) 2006-08-23 2010-10-26 Teva Pharmaceutical Industries Ltd. Process for the synthesis of CMHTP and intermediates thereof
WO2008024415A2 (en) * 2006-08-23 2008-02-28 Teva Pharmaceutical Insustries Ltd. Process for the synthesis of cmhtp and intermediates thereof
US8071767B2 (en) * 2007-01-08 2011-12-06 Actavis Group Ptc Ehf Process for preparation of 9-hydroxy-3-(2-chloroethyl)-2-methyl-4H-pyrido[1,2-A]pyrimidin-4-one hydrochloride
WO2008126886A1 (ja) * 2007-04-12 2008-10-23 Taisho Pharmaceutical Co., Ltd. インドール又はインドリン誘導体
WO2009010988A1 (en) * 2007-07-19 2009-01-22 Natco Pharma Limited An improved, industrially viable process for the preparation of high purity paliperidone
WO2012177708A1 (en) 2011-06-20 2012-12-27 Ratiopharm Gmbh Paliperidone oleate
US9951038B2 (en) 2012-12-27 2018-04-24 Purdue Pharma L.P. Quinazolin-4(3H)-one-type piperidine compounds and uses thereof
US9963458B2 (en) 2012-12-27 2018-05-08 Purdue Pharma L.P. Indole and indoline-type piperidine compounds and uses thereof
CN117700410B (zh) * 2023-05-20 2025-07-04 山东康诺生物工程有限公司 一种3-(2-氯乙基)-2-甲基-9-羟基-4H-吡啶并[1,2-a]嘧啶-4-酮的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4342870A (en) * 1980-03-28 1982-08-03 Janssen Pharmaceutica N.V. Novel 3-(1-piperidinylalkyl)-4H-pyrido[1,2-a]pyrimidin-4-one derivatives
US4443451A (en) * 1981-07-15 1984-04-17 Janssen Pharmaceutica N.V. Bicyclic pyrimidin-5-one derivatives
US5256659A (en) * 1989-01-09 1993-10-26 Janssen Pharmaceutica N.V. 2-aminopyrimidinone derivatives
GB8900382D0 (en) * 1989-01-09 1989-03-08 Janssen Pharmaceutica Nv 2-aminopyrimidinone derivatives
US5140029A (en) * 1989-01-09 1992-08-18 Janssen Pharmaceutica N.V. 2-aminopyrimidinone derivatives
JP2800953B2 (ja) * 1990-07-06 1998-09-21 住友製薬株式会社 新規なイミド誘導体
US5360807A (en) * 1990-07-19 1994-11-01 Janssen Pharmaceutica N.V. Substituted thiazolyl and substituted pyridinyl derivatives
DK181190D0 (da) * 1990-07-30 1990-07-30 Lundbeck & Co As H 3-aryl-indol- eller 3-aryl-indazolderivater
GB9305641D0 (en) * 1993-03-18 1993-05-05 Merck Sharp & Dohme Therapeutic agents

Also Published As

Publication number Publication date
CA2210913C (en) 2008-10-21
PL183291B1 (pl) 2002-06-28
EP0808313B1 (en) 2003-08-13
FI973164A0 (sv) 1997-07-30
MY130950A (en) 2007-07-31
NO973508L (no) 1997-07-30
AR002025A1 (es) 1998-01-07
CN1172482A (zh) 1998-02-04
JPH10512893A (ja) 1998-12-08
MX9705821A (es) 1997-10-31
WO1996023784A1 (en) 1996-08-08
US5919788A (en) 1999-07-06
ZA96702B (en) 1997-07-30
DE69629454T2 (de) 2004-06-17
NO308537B1 (no) 2000-09-25
EP0808313A1 (en) 1997-11-26
KR100415391B1 (ko) 2004-05-06
ES2205015T3 (es) 2004-05-01
KR19980701692A (ko) 1998-06-25
PL321565A1 (en) 1997-12-08
IL116930A (en) 2000-06-29
CN1152874C (zh) 2004-06-09
TW421649B (en) 2001-02-11
NZ301264A (en) 1998-07-28
ATE247105T1 (de) 2003-08-15
NO973508D0 (no) 1997-07-30
DE69629454D1 (en) 2003-09-18
IL116930A0 (en) 1996-05-14
AU702931B2 (en) 1999-03-11
AU4664596A (en) 1996-08-21
CA2210913A1 (en) 1996-08-08
JP3980054B2 (ja) 2007-09-19
FI973164L (sv) 1997-07-30
BR9606815A (pt) 1997-12-30

Similar Documents

Publication Publication Date Title
ATE278695T1 (de) Piperidinderivate
FI955184L (sv) Benzylpiperidinderivat
FI941022L (sv) Spirocykliska piperidinderivat
DK0842170T3 (da) Diphenylmethylen-piperidin-derivater
ATE207899T1 (de) 4-hydroxypiperidinderivate
ATE353326T1 (de) Piperazin-derivate
FI921345L (fi) Piperidinderivat
DK1131308T3 (da) Piperazin- og piperidinderivater
ATE202078T1 (de) 2-(4-substituierte)-benzylamino-2-methyl- propanamid-derivate
FI973164A7 (sv) Antipsykotiska 4-(1H-indolyl-1-yl)-1-substituerade piperidinderivat
FI932173L (fi) 4-(1,2-benzisoxazolyl)piperidinantipsykotiska medel
FI923664L (fi) Piperidinderivat
FI970110A0 (sv) Anti-Helicobakteriska heterocykliska azolonderivat
DE69216260D1 (de) Piperidinderivate
NO992302L (no) Piperidin-derivater
DK0937458T3 (da) Pyrrolidin- og piperidinderivater
DE69706813D1 (de) 4-Hydroxypiperidinderivate
HU9800707D0 (en) Phenoxymethyl piperidine derivatives
NO20001778L (no) Substituerte piperidinderivater
KR970006301A (ko) -피페리딘 또는 테트라하이드로피리딘 아자비사이클로카복스아미드
HK1028765A (en) Antipsychotic substituted piperidine derivatives
DK0886645T3 (da) Nye 19-nor-pregnen-derivater
BR1100219A (pt) Derivados de diidropiridina

Legal Events

Date Code Title Description
FD Application lapsed